Visser WH - Search Results

1

Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan.

Rapoport AM, Visser WH, Cutler NR, Alderton CJ, Paulsgrove LA, Davis RL, Ferrari MD. Rapoport AM, et al. Among authors: visser wh. Neurology. 1995 Aug;45(8):1505-9. doi: 10.1212/wnl.45.8.1505. Neurology. 1995. PMID: 7644049 Clinical Trial.

2

311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.

Visser WH, Klein KB, Cox RC, Jones D, Ferrari MD. Visser WH, et al. Neurology. 1996 Feb;46(2):522-6. doi: 10.1212/wnl.46.2.522. Neurology. 1996. PMID: 8614525 Clinical Trial.

3

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients.

Visser WH, de Vriend RH, Jaspers MW, Ferrari MD. Visser WH, et al. Neurology. 1996 Jul;47(1):46-51. doi: 10.1212/wnl.47.1.46. Neurology. 1996. PMID: 8710123

4

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.

Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD. Visser WH, et al. Arch Neurol. 1996 Nov;53(11):1132-7. doi: 10.1001/archneur.1996.00550110072014. Arch Neurol. 1996. PMID: 8912486 Clinical Trial.

5

Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.

Visser WH, Ferrari MD, Bayliss EM, Ludlow S, Pilgrim AJ. Visser WH, et al. Cephalalgia. 1992 Oct;12(5):308-13. doi: 10.1046/j.1468-2982.1992.1205308.x. Cephalalgia. 1992. PMID: 1330318 Clinical Trial.

6

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients.

Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Visser WH, et al. Cephalalgia. 1996 Jun;16(4):264-9. doi: 10.1046/j.1468-2982.1996.1604264.x. Cephalalgia. 1996. PMID: 8792039

7

Sumatriptan-nonresponders: a survey in 366 migraine patients.

Visser WH, de Vriend RH, Jaspers NH, Ferrari MD. Visser WH, et al. Headache. 1996 Sep;36(8):471-5. doi: 10.1046/j.1526-4610.1996.3608471.x. Headache. 1996. PMID: 8824001

8

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.

Visser WH, Burggraaf J, Muller LM, Schoemaker RC, Fowler PA, Cohen AF, Ferrari MD. Visser WH, et al. Clin Pharmacol Ther. 1996 Oct;60(4):452-60. doi: 10.1016/S0009-9236(96)90202-7. Clin Pharmacol Ther. 1996. PMID: 8873693 Clinical Trial.

9

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.

Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Visser WH, et al. Cephalalgia. 1996 Dec;16(8):554-9. doi: 10.1046/j.1468-2982.1996.1608554.x. Cephalalgia. 1996. PMID: 8980858

10

[Sumatriptan in clinical practice].

Ferrari MD, Haan J, Visser WH, Saxena PR, Bax WA, Mulder LJ. Ferrari MD, et al. Among authors: visser wh. J Pharm Belg. 1993 Nov-Dec;48(6):471-8. J Pharm Belg. 1993. PMID: 8133429 Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters